If we go back Amarex's CEO and his excitement abou
Post# of 148288
(Total Views: 458)
Posted On: 11/01/2022 2:37:32 PM
Re: Evil Rabbit #129957
If we go back Amarex's CEO and his excitement about the Covid trial to be run with Leronlimab and Remdesivir and how they were going to help bring an EUA to Leronlimab during the crisis and then by June 2020 we running into no response from Amarex. You would think with the tremendous potential for money they would have been on top of every detail of Leronlimab trials.
Yet here is Recknor in like Fall 2020: 20. Amarex has failed to provide CytoDyn with requested information for work it claims it has performed.
21. One of the ways CytoDyn has confirmed that Amarex is not performing under the MSA and the Work Orders is by downloading a snapshot of the clinical data for certain clinical trials managed by Amarex.
CytoDyn stands ready to take on responsibility for monitoring the ongoing trials.
In order to manage the ongoing clinical trials, however, CytoDyn needs full access from the clinical trials, including the EDC database.
CytoDyn has repeatedly requested that Amarex give it access to its own EDCs and but Amarex has refused.
Yet here is Recknor in like Fall 2020: 20. Amarex has failed to provide CytoDyn with requested information for work it claims it has performed.
21. One of the ways CytoDyn has confirmed that Amarex is not performing under the MSA and the Work Orders is by downloading a snapshot of the clinical data for certain clinical trials managed by Amarex.
CytoDyn stands ready to take on responsibility for monitoring the ongoing trials.
In order to manage the ongoing clinical trials, however, CytoDyn needs full access from the clinical trials, including the EDC database.
CytoDyn has repeatedly requested that Amarex give it access to its own EDCs and but Amarex has refused.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼